Position in INSM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$8,812,092
-$594,247 QoQ
Shares Held
53,890
-0.3% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $291,138,584 across 78 Biotechnology names. INSM ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
192,144 | $85,799,981 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,886 | $60,950,479 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,255 | $18,943,961 | |
| 4 | INCY |
Incyte Corp
|
111,609 | $10,504,639 | |
| 5 | INSM |
INSMED Inc
This page
|
53,890 | $8,812,092 | |
| 6 | ARGX |
Argenx SE
|
11,567 | $8,446,801 | |
| 7 | MRNA |
Moderna, Inc.
|
148,181 | $7,527,594 | |
| 8 | EXEL |
Exelixis, Inc.
|
167,451 | $7,181,973 |
All Filings in INSM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,812,092 | 53,890 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $9,406,339 | 54,047 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,774,518 | 47,042 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $4,654,600 | 46,250 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $3,239,120 | 42,458 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,718,726 | 39,379 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,760,203 | 37,811 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,118,381 | 46,543 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,362,685 | 50,228 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,555,636 | 50,198 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $980,710 | 38,840 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $615,065 | 29,150 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $411,331 | 24,125 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $136,423 | 6,828 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $125,298 | 5,817 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $114,711 | 5,817 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $136,699 | 5,817 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $158,455 | 5,817 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $160,200 | 5,817 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $165,551 | 5,817 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $238,930 | 7,015 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $233,529 | 7,015 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $225,462 | 7,015 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $193,193 | 7,015 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $89,944 | 5,611 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||